相关论文: A Latent Risk-Aware Machine Learning Approach for …
Clinical trials are pivotal for developing new medical treatments but typically carry risks such as patient mortality and enrollment failure that waste immense efforts spanning over a decade. Applying artificial intelligence (AI) to predict…
Clinical trial outcome prediction seeks to estimate the likelihood that a clinical trial will successfully reach its intended endpoint. This process predominantly involves the development of machine learning models that utilize a variety of…
Clinical trials constitute a critical yet exceptionally challenging and costly stage of drug development (\$2.6B per drug), where protocols are encoded as complex natural language documents, motivating the use of AI systems beyond manual…
Although recent multi-task learning methods have shown to be effective in improving the generalization of deep neural networks, they should be used with caution for safety-critical applications, such as clinical risk prediction. This is…
The impact of machine learning models on healthcare will depend on the degree of trust that healthcare professionals place in the predictions made by these models. In this paper, we present a method to provide people with clinical expertise…
This research presents preliminary work to address the challenge of identifying at-risk students using supervised machine learning and three unique data categories: engagement, demographics, and performance data collected from Fall 2023…
Predicting the performance of LLMs on individual task instances is essential to ensure their reliability in high-stakes applications. To do so, a possibility is to evaluate the considered LLM on a set of task instances and train an assessor…
Clinical trials need to recruit a sufficient number of volunteer patients to demonstrate the statistical power of the treatment (e.g., a new drug) in curing a certain disease. Clinical trial recruitment has a significant impact on trial…
Machine learning (ML) underpins foundation models in finance, healthcare, and critical infrastructure, making them targets for data poisoning, model extraction, prompt injection, automated jailbreaking, and preference-guided black-box…
LLM based agents have recently demonstrated strong potential in automating complex tasks, yet accurately predicting startup success remains an open challenge with few benchmarks and tailored frameworks. To address these limitations, we…
A major impediment to successful drug development is the complexity, cost, and scale of clinical trials. The detailed internal structure of clinical trial data can make conventional optimization difficult to achieve. Recent advances in…
Although general-purpose AI systems offer transformational opportunities in science and industry, they simultaneously raise critical concerns about safety, misuse, and potential loss of control. Despite these risks, methods for assessing…
Performance regression testing is essential in large-scale continuous-integration (CI) systems, yet executing full performance suites for every commit is prohibitively expensive. Prior work on performance regression prediction and batch…
We offer a pragmatic model to operationalize responsible, secure, and sustainable healthcare AI, aligning world-class technical excellence with organizational readiness. The framework includes five key pillars - Leadership & Strategy, MLOps…
Large Language Models (LLMs) are increasingly integrated into critical decision-making pipelines, a trend that raises the demand for robust and automated data analysis. Current approaches to dataset risk analysis are limited to manual…
The development of artificial intelligence can be viewed as an evolution of data-driven learning paradigms, with successive shifts in data organization and utilization continuously driving advances in model capability. Current LLM research…
This work presents the development and evaluation of an NLP-enabled probabilistic classifier designed to estimate the probability of technical and regulatory success (pTRS) for clinical trials in the field of neuroscience. While…
Early-stage startup investment is a high-risk endeavor characterized by scarce data and uncertain outcomes. Traditional machine learning approaches often require large, labeled datasets and extensive fine-tuning, yet remain opaque and…
Deep learning models are widely used across computer vision and other domains. When working on the model induction, selecting the right architecture for a given dataset often relies on repetitive trial-and-error procedures. This procedure…
Anti-money laundering (AML) actions and measurements are among the priorities of financial institutions, for which machine learning (ML) has shown to have a high potential. In this paper, we propose a comprehensive and systematic approach…